Jennifer McElhattan

842 total citations
11 papers, 676 citations indexed

About

Jennifer McElhattan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jennifer McElhattan has authored 11 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jennifer McElhattan's work include Asthma and respiratory diseases (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Jennifer McElhattan is often cited by papers focused on Asthma and respiratory diseases (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Jennifer McElhattan collaborates with scholars based in United States, Canada and United Kingdom. Jennifer McElhattan's co-authors include Jay R. Lieberman, Scott D. Berkowitz, Clifford W. Colwell, Jeffrey S. Ginsberg, Gary Peters, Donald P. Tashkin, Stephen I. Rennard, Ubaldo J. Martin, Charles W. Francis and Philip C. Comp and has published in prestigious journals such as New England Journal of Medicine, Journal of Bone and Joint Surgery and CHEST Journal.

In The Last Decade

Jennifer McElhattan

11 papers receiving 654 citations

Peers

Countries citing papers authored by Jennifer McElhattan

Since Specialization

Citations

This map shows the geographic impact of Jennifer McElhattan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer McElhattan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer McElhattan more than expected).

Fields of papers citing papers by Jennifer McElhattan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer McElhattan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer McElhattan. The network helps show where Jennifer McElhattan may publish in the future.

Co-authorship network of co-authors of Jennifer McElhattan

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer McElhattan. A scholar is included among the top collaborators of Jennifer McElhattan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer McElhattan. Jennifer McElhattan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials 2020 ·The Lancet Respiratory Medicine ·Jonathan A. Bernstein, J. Christian Virchow, Kevin R. Murphy, Jorge Máspero, Joshua Jacobs, Yochai Adir, Marc Humbert, Mario Castro, Douglas Marsteller, Jennifer McElhattan, Lisa Hickey, Margaret Garin, (unknown), Guy Brusselle	57
2	Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials 2016 ·Guy Brusselle, Jennifer McElhattan, Janice Canvin, Roland Buhl	4
3	Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD 2011 ·Respiratory Medicine ·Bartolomé R. Celli, Donald P. Tashkin, Stephen I. Rennard, Jennifer McElhattan, Ubaldo J. Martin	23
4	Bronchodilator Responsiveness to Formoterol (FM)-Containing Treatments by Chronic Obstructive Pulmonary Disease (COPD) Severity Classification 2010 ·Journal of Allergy and Clinical Immunology ·Donald P. Tashkin, Bartolomé R. Celli, Stephen I. Rennard, Jennifer McElhattan, Ubaldo J. Martin	1
5	Efficacy and Tolerability of Fixed-Dose (FD) and Adjustable-Dose (AD) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) and FD Fluticasone Propionate/Salmeterol Dry Powder Inhaler (FP/SAL DPI) Within Racial Groups 2009 ·Journal of Allergy and Clinical Immunology ·Shailen Shah, William W. Busse, Jennifer McElhattan, Christopher D. O’Brien, M. Goldman	4
6	Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease 2009 ·Drugs ·Stephen I. Rennard, Donald P. Tashkin, Jennifer McElhattan, Mitchell Goldman, Sulabha Ramachandran, Ubaldo J. Martin, Philip E. Silkoff	165
7	LONG-TERM TOLERABILITY OF BUDESONIDE AND FORMOTEROL ADMINISTERED IN ONE PRESSURIZED METERED-DOSE INHALER IN PATIENTS WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2008 ·CHEST Journal ·Stephen I. Rennard, Donald P. Tashkin, Jennifer McElhattan, Mitchell Goldman, Philip E. Silkoff	3
8	A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitus 2007 ·Diabetes and Vascular Disease Research ·Harold Bays, Jennifer McElhattan, Brian Bryzinski	37
9	ORAL DIRECT THROMBIN INHIBITOR XIMELAGATRAN COMPARED WITH WARFARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE ARTHROPLASTY 2005 ·Journal of Bone and Joint Surgery ·Clifford W. Colwell, Scott D. Berkowitz, Jay R. Lieberman, Philip C. Comp, Jeffrey S. Ginsberg, Guy D. Paiement, Jennifer McElhattan, (unknown), Charles W. Francis	22
10	Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study 2003 ·Journal of Thrombosis and Haemostasis ·Clifford W. Colwell, Scott D. Berkowitz, Bruce L. Davidson, Paul A. Lotke, Jeffrey S. Ginsberg, Jay R. Lieberman, Jacqueline Neubauer, Jennifer McElhattan, Gary Peters, C. W. Francis	119
11	Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee Replacement 2003 ·New England Journal of Medicine ·Charles W. Francis, Scott D. Berkowitz, Philip C. Comp, Jay R. Lieberman, Jeffrey S. Ginsberg, Guy D. Paiement, Gary Peters, (unknown), Jennifer McElhattan, Clifford W. Colwell	241

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact